Share:
Research Letter

Ribociclib-Induced Vitiligo: A Case Report

Author Affiliation(s)

Abstract

References

1. Rascon K, Flajc G, De Angelis C, Liu X, Trivedi MV, Ekinci E. Ribociclib in HR+/HER2- Advanced or Metastatic Breast Cancer Patients. Ann Pharmacother 2019;53:501–9. DOI: 10.1177/1060028018817904. 2. Sollena P, Nikolaou V, Soupos N, et al. Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors. Breast Cancer Res Treat 2021;185(1):247-253. DOI: 10.1007/s10549-020-05914-w.

Send mail to Author


Send Cancel